Webdisclosure.com

Search

SANOFI-AVENTIS (EPA:SAN) Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis

Directive transparence : information réglementée

20/05/2022 21:15